SAMUELSON DOUG (Chief Financial Officer) purchased 4.3% of their position (2.50K shares) of KAIROS PHARMA, LTD. on the open market
Open‑market purchase worth $3.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/25/2024ACC: 0001493152-24-047526
Officer· Chief Financial Officer
Since Sep 2024
+2.50K
Net shares
Net buyer
$3.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+2.50K
Price / share
$1.50
Trade value
$3.75K
% of position
4.3%
11/22/2024
58.30K→60.80K
Total
Net shares
+2.50K
Net value
$3.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 11/22/2024 | P · Purchase | +2.50K | $1.50 | $3.75K | 4.3% | 58.30K | 60.80K |
| Total | +2.50K | $3.75K | ||||||
Derivative Transactions0
No derivative transactions reported